Sampled has partnered with AutoGen recently to advance nucleic acid extraction and multiomic workflows in biomedical research. The collaboration aims to streamline the process of deriving high-quality DNA and RNA from biospecimens—a critical step for ensuring sample integrity and reproducibility across research applications.
Although the companies did not specifically reference any biobanking standards, the partnership reflects broader industry goals for data quality, traceability, and reproducibility emphasized in the ISBER Best Practices and the ISO 20387:2018.
Ensuring Quality and Standardization in Sample Processing
Efficient nucleic acid extraction underpins every stage of biobank-enabled research, from next-generation sequencing (NGS) to transcriptomic and proteomic analyses. According to the ISBER Best Practices (5th Edition), standardized extraction and processing procedures are vital to maintaining biospecimen quality and enabling comparability across studies.
By integrating AutoGen’s automated extraction technologies with Sampled’s biobanking and multiomic services, the partnership demonstrates a move toward greater alignment with internationally recognized standards such as ISO 20387, which defines quality management principles for competent and consistent biobank operations.
Complementary Strengths in Nucleic Acid Extraction
AutoGen brings more than 25 years of expertise in automated nucleic acid extraction and reagent development, supporting a diverse range of sample types, including blood, FFPE tissues, plants, and liquid biopsies. Sampled, a CAP-accredited and CLIA-licensed biorepository, complements these capabilities with comprehensive multiomic, cellular, and histology services across its facilities in the United States and the United Kingdom.
Together, the two companies provide an end-to-end pipeline that transforms raw biological materials into data-ready analytes for advanced biomedical research, supporting scientists and institutions seeking scalable, compliant, and reproducible workflows.
Implications for the Biobanking Community
As biobanks evolve into integrated multiomic data hubs, collaborations between biorepositories and technology providers highlight the growing convergence of infrastructure, automation, and analytical expertise. While not a certification claim, the approach taken by Sampled and AutoGen reflects principles encouraged in the ISBER and ISO frameworks—emphasizing quality assurance, interoperability, and continuous improvement throughout the biospecimen lifecycle.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and sample/biospecimen management, while connects buyers with top vendors globally.
